KR20110020784A - Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제 - Google Patents

Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제 Download PDF

Info

Publication number
KR20110020784A
KR20110020784A KR1020107026507A KR20107026507A KR20110020784A KR 20110020784 A KR20110020784 A KR 20110020784A KR 1020107026507 A KR1020107026507 A KR 1020107026507A KR 20107026507 A KR20107026507 A KR 20107026507A KR 20110020784 A KR20110020784 A KR 20110020784A
Authority
KR
South Korea
Prior art keywords
alkyl
hydrogen
optionally substituted
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020107026507A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 페스투스 찰스 모패트
스테펜 존 데이비스
Original Assignee
크로마 세러퓨틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0807642A external-priority patent/GB0807642D0/en
Priority claimed from GB0815550A external-priority patent/GB0815550D0/en
Application filed by 크로마 세러퓨틱스 리미티드 filed Critical 크로마 세러퓨틱스 리미티드
Publication of KR20110020784A publication Critical patent/KR20110020784A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
KR1020107026507A 2008-04-26 2009-04-23 Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제 Withdrawn KR20110020784A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0807642.4 2008-04-26
GB0807642A GB0807642D0 (en) 2008-04-26 2008-04-26 IKK- serine-threonine protein kinase inhibitors
GB0815550A GB0815550D0 (en) 2008-08-27 2008-08-27 IKK-beta serine-threonine protein kinase inhibitors
GB0815550.9 2008-08-27

Publications (1)

Publication Number Publication Date
KR20110020784A true KR20110020784A (ko) 2011-03-03

Family

ID=40786701

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107026507A Withdrawn KR20110020784A (ko) 2008-04-26 2009-04-23 Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제

Country Status (13)

Country Link
US (1) US20110046210A1 (https=)
EP (1) EP2285797A1 (https=)
JP (1) JP2011518817A (https=)
KR (1) KR20110020784A (https=)
CN (1) CN102036980A (https=)
AU (1) AU2009239772A1 (https=)
BR (1) BRPI0911480A2 (https=)
CA (1) CA2722660A1 (https=)
EA (1) EA201001708A1 (https=)
IL (1) IL208654A0 (https=)
MX (1) MX2010011643A (https=)
WO (1) WO2009130475A1 (https=)
ZA (1) ZA201008027B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012176930A (ja) * 2010-10-07 2012-09-13 Santen Pharmaceut Co Ltd ウレイド基とアミノカルボニル基を置換基として有するチオフェン誘導体を有効成分として含有する新規ｊａｋ３阻害剤
GB201211310D0 (en) 2012-06-26 2012-08-08 Chroma Therapeutics Ltd CSF-1R kinase inhibitors
HUE046132T2 (hu) 2012-10-17 2020-02-28 Macrophage Pharma Ltd N-[2-{4-[6-amino-5-(2,4-difluor-benzoil)-2-oxopiridin-1(2H)-il]-3,5-difluor-fenil}etil]-l-alanin és annak tercbutil-észtere
ES2656012T3 (es) 2013-02-06 2018-02-22 Bayer Cropscience Aktiengesellschaft Derivados de pirazol sustituidos con halógeno como pesticidas
GB201713975D0 (en) 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
WO2008002246A1 (en) * 2006-06-28 2008-01-03 Astrazeneca Ab A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient.
EA200900616A1 (ru) * 2006-11-01 2010-04-30 Хрома Терапьютикс Лтд. Ингибиторы ikk-бета серин-треонин протеинкиназы
ATE524454T1 (de) * 2006-11-01 2011-09-15 Chroma Therapeutics Ltd Inhibitoren von ikk-beta serinthreoninproteinkinase

Also Published As

Publication number Publication date
CA2722660A1 (en) 2009-10-29
EA201001708A1 (ru) 2011-06-30
BRPI0911480A2 (pt) 2018-04-03
EP2285797A1 (en) 2011-02-23
ZA201008027B (en) 2011-07-27
IL208654A0 (en) 2010-12-30
US20110046210A1 (en) 2011-02-24
CN102036980A (zh) 2011-04-27
JP2011518817A (ja) 2011-06-30
MX2010011643A (es) 2010-11-30
WO2009130475A1 (en) 2009-10-29
AU2009239772A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
EP2078007B1 (en) Ikk-beta serine-threonine protein kinase inhibitors
EP2013175B9 (en) p38 MAP KINASE INHIBITORS
EP2086956B1 (en) Inhibitors of ikk- beta serine-threonine protein kinase
EP2296662A1 (en) Inhibitors of plk
WO2008050078A1 (en) Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
KR20090087013A (ko) 히스톤 탈아세틸효소의 억제제로서 히드록사메이트
KR20100126762A (ko) 세포내 효소 및 수용체 조절
KR20110020784A (ko) Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제
KR20110021799A (ko) Ｉｋｋ-베타 세린-트레오닌 단백질 키나아제의 억제제
WO2008053158A1 (en) Inhibitors of p38 mitogen-activated protein kinase
EP2421844A1 (en) Thiophene inhibitors of ikk-b serine-threonine protein kinase
WO2009141575A1 (en) Inhibitors of plk
CN101541779A (zh) IKK-β丝氨酸-苏氨酸蛋白激酶抑制剂
AU2006350475B2 (en) Hydroxamates as inhibitors of histone deacetylase

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20101126

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid